Mechanisms of resistance against cyclophosphamide and ifosfamide: can they be overcome without sacrificing selectivity?

Cancer treatment and research

Volumn 112, Issue , 2002, Pages 177-197

  Ludeman, Susan M ^a   Gamcsik, Michael P ^a  

^a DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; ALDEHYDE DEHYDROGENASE; ALKYLATING AGENT; CYCLOPHOSPHAMIDE; IFOSFAMIDE; ISOPHOSPHAMIDE MUSTARD; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHORAMIDE MUSTARD;

CHEMICAL MODEL; DNA REPAIR; DRUG RESISTANCE; HUMAN; METABOLISM; REVIEW; STEREOISOMERISM;

ACROLEIN; ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; HUMANS; IFOSFAMIDE; MODELS, CHEMICAL; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PHOSPHORAMIDE MUSTARDS; STEREOISOMERISM;

MLCS; MLOWN;

EID: 1842865948     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-1173-1_9     Document Type: Review

References (90)